Xavier Roblin
Université Claude Bernard Lyon 1(FR)École Normale Supérieure de Lyon(FR)Centre National de la Recherche Scientifique(FR)Inserm(FR)Privy Council Office(CA)Institute Cancer De La Loire Lucien Neuwirth(FR)Centre Hospitalier Universitaire de Saint-Étienne(FR)Centre International de Recherche en Infectiologie(FR)Université Jean Monnet(FR)
Publications by Year
Research Areas
Inflammatory Bowel Disease, Microscopic Colitis, Immunodeficiency and Autoimmune Disorders, Chronic Lymphocytic Leukemia Research, Autoimmune and Inflammatory Disorders
Most-Cited Works
- → Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial(2012)634 cited
- → Clinical remission in patients with moderate-to-severe Crohn's disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-controlled trial(2016)432 cited
- → Efficacy of adalimumab in patients with Crohn's disease and symptomatic small bowel stricture: a multicentre, prospective, observational cohort (CREOLE) study(2017)321 cited
- → Association Between Pharmacokinetics of Adalimumab and Mucosal Healing in Patients With Inflammatory Bowel Diseases(2013)275 cited
- → Therapeutic Drug Monitoring of Infliximab and Mucosal Healing in Inflammatory Bowel Disease(2013)220 cited
- → Preoperative use of anti-TNF therapy and postoperative complications in inflammatory bowel diseases: A meta-analysis